Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Kiadis Pharma Netherlands B.V. logo — Empowering hope in blood cancer treatment with innovative th...

Kiadis Pharma Netherlands B.V.

Empowering hope in blood cancer treatment with innovative therapies to meet high-unmet medical needs.

Founded 1997 2 employees Post-IPO Equity Total: $73.01M Biopharma, Biotechnology +1

General Information

Company Name Kiadis Pharma Netherlands B.V.
Founded Year 1997
Founders / Decision Makers
Team member Team member
Employees 2
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Kiadis Pharma Netherlands B.V.. To contact Kiadis Pharma Netherlands B.V., visit kiadis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Kiadis Pharma Netherlands B.V. compare?

A PDF of Kiadis Pharma Netherlands B.V. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Kiadis Pharma Netherlands B.V. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Kiadis Pharma Netherlands B.V.

Kiadis Pharma is a biopharmaceutical company headquartered in Amsterdam, The Netherlands. Established in 1997, the company is dedicated to addressing complications and limitations associated with hematopoietic stem cell transplants in blood cancer patients. With a focus on the Biopharma, Biotechnology, and Pharmaceutical industries, Kiadis Pharma is advancing three blood cancer products in clinical development, offering innovative treatment options for terminally ill cancer patients with high unmet medical needs. The latest milestone for Kiadis Pharma involved a €8.01M Post-IPO Equity investment on 15 September 2020. This investment signifies confidence in the company's commitment to empowering hope in blood cancer treatment and its potential to meet high-unmet medical needs.

Business keywords: Kiadis Pharma, biopharmaceutical company, hematopoietic stem cell transplants, blood cancer treatment, clinical development, innovative therapies, high-unmet medical needs, complications, limitations, Amsterdam, Netherlands

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity €8.01M -
15 Sep 2020
Post IPO Equity €5.00M 1
EQT Life Sciences
30 Apr 2020
Post IPO Debt €20.00M 1
Kreos Capital
Kreos Capital
01 Aug 2018
Post IPO Debt €15.00M 1
Kreos Capital
Kreos Capital
17 Aug 2017
Venture Round €10.00M 4
Molten Ventures Alta Partners Quest for Growth
Molten Ventures, Alta Partners +2
20 Nov 2012
Venture Round €15.00M 4
Alta Partners Quest for Growth MedSciences Capital
Alta Partners, Quest for Growth +2
26 Jun 2007

Kiadis Pharma Netherlands B.V. Alternatives & Competitors

View All Alternatives
Kiadis Pharma Netherlands B.V. vs
Agennix
Agennix

Crafting novel therapies to enhance the length and quality of life for seriously ill patients worldw...

Venture round
Biopharma, Biotechnology
Kiadis Pharma Netherlands B.V. vs
AbilityPharma
AbilityPharma Spain

Advancing cancer treatment through innovative therapeutics targeting cell membranes.

Venture round
23 employees
Biotechnology, Health Care
Kiadis Pharma Netherlands B.V. vs
MediciNova
MediciNova

Focused on innovative small-molecule therapeutics, addressing unmet medical needs with strategic all...

Post-IPO Equity
Biotechnology, Health and Wellness
View all alternatives

FAQ About Kiadis Pharma Netherlands B.V.

Empowering hope in blood cancer treatment with innovative therapies to meet high-unmet medical needs.
Kiadis Pharma Netherlands B.V. was founded in 1997.
Kiadis Pharma Netherlands B.V. operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on Kiadis Pharma, biopharmaceutical company, hematopoietic stem cell transplants and blood cancer treatment.
Kiadis Pharma Netherlands B.V. has approximately 2 employees.
Kiadis Pharma Netherlands B.V. has completed 6 funding rounds, raising a total of $73.01M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Kiadis Pharma Netherlands B.V. include Agennix, AbilityPharma, MediciNova, AlloMek Therapeutics LLC, Cage Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kiadis Pharma Netherlands B.V. and Agennix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Kiadis Pharma Netherlands B.V., https://bouncewatch.com/company/kiadis-pharma, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes